| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $26.20M | - | |
| COO | 145.4K | $8.86M | - | |
| CFO | 95.3K | $5.81M | - | |
| Other | 68.1K | $4.15M | - | |
| Other | 52.6K | $3.21M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2021 | Robert Lorne Hopfner | Director | Sell | 2,000 | $25.07 | $50,140.00 | -0.1% | |
| Jan 27, 2021 | Robert Lorne Hopfner | Director | Sell | 55,254 | $25.62 | $1,415,845.34 | -3.0% | |
| Jan 26, 2021 | Jeff Fairman | VP, Research | Sale+OE | 4,750 | $25.27 | $120,014.50 | -77.1% | |
| Jan 22, 2021 | Robert Lorne Hopfner | Director | Sell | 30,529 | $25.28 | $771,723.38 | -1.6% | |
| Jan 20, 2021 | Jim Wassil53 | Chief Operating Officer | Sale+OE | 3,000 | $25.50 | $76,500.00 | -15.5% | |
| Jan 19, 2021 | Grant Pickering50 | President & CEO | Sale+OE | 15,000 | $25.10 | $376,497.62 | -2.5% | |
| Jan 19, 2021 | Robert Lorne Hopfner | Director | Sell | 91,111 | $25.71 | $2,342,558.10 | -4.6% | |
| Jan 15, 2021 | Jane Wright-Mitchell65 | General Counsel | Sale+OE | 2,500 | $26.00 | $65,000.00 | -61.5% | |
| Jan 13, 2021 | Robert Lorne Hopfner | Director | Sell | 97,343 | $26.29 | $2,558,948.07 | -4.7% | |
| Jan 11, 2021 | Paul Sauer | SVP Process Dev, Manufacturing | Sale+OE | 2,500 | $26.21 | $65,526.72 | -3.1% |